Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.
Cagent Vascular, Inc., the exclusive developer of serration technology for vessel dilation in endovascular interventions, ...
Teleflex management announced a significant acquisition and business split, but the market reacted negatively. Read why I remain neutral on TFX stock.
In 2006, Abbott acquired Guidant, a leader in coronary and vascular products, and Kos Pharmaceuticals, a speciality pharma company with a significant lipid management portfolio. In 2009 ...
and Abbott (NYSE: ABT). With a proven track record of driving revenue growth, expanding market share, and fostering strategic partnerships, he will play a critical role in scaling Cagent Vascular ...
The Vietnam baby food products market is projected to experience a steady growth rate, with a CAGR of 1.53% during the forecast period from 2025 to 2032. The market, valued at $1303.60 million in 2024 ...
9d
The Healthy @Reader's Digest on MSNIf You Have High Cholesterol, Limit These 7 FoodsLooking for ways to manage high cholesterol? A leading cardiologist and top dietitian say fried foods and meat aren't the ...
The global AI in Remote Patient Monitoring Market, valued at US$1551.8 million in 2023, is forecasted to grow at a robust ...
Stocks like India Pesticides, HFCL, NDR Auto Components, JSW Steel, GR Infraprojects, Biocon, Oil and Natural Gas Corporation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results